<< PositiveID, Receptors announce milestone in development of in vivo glucose-sensing RFID microchip | Melanin-covered nanoparticles may protect bone marrow from harmful radiation therapy effects: Research >>

Proton Laboratories posts additional information on OTCMarkets.com

Published on April 27, 2010 at 5:23 AM · No Comments

Proton Laboratories, Inc. (Pink Sheets:PLBI) announced today that it has posted additional information on OTCMarkets.com (formerly pinksheets.com) relating to its 12/31/09 balance sheet status having engaged the accounting firm of Davis Sita & Company P.A. of Greenbelt Maryland.

We are working to bring all historical financial information together for 2009 and 2008 as required by OTCMarkets' guidelines by month end as we obtain additional data from past management.

SOURCE Proton Laboratories, Inc.

21be6694-2125-4143-885a-3682f39d76f3|0|.0

Posted in:

Tags: Cell, Stem Cell, Transplant

Losartan may help prevent smoking-related COPDWorking with mice, scientists at Johns Hopkins have successfully used a commonly prescribed blood pr...
Phase IIb study of EVP-6124 initiated in patients with Alzheimer's diseaseEnVivo Pharmaceuticals today announced the initiation and dosing of patients in a Phase IIb study of...
PBI and TDI announce strategic licensing and collaborative research and development agreementPressure BioSciences, Inc. and Target Discovery, Inc.,, today announced a strategic product licensin...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.